Roivant Sciences Ltd. Warrant (ROIVW) Key Ratios
$2.75
As on 01-Sep-2023 15:45EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -21.01 | 400.67 | 51.50 | -- | -- |
| EBIT | -26.88 | -5.25 | 26.09 | -- | -- |
| Net Profit | -72.62 | 22.91 | 0.82 | -- | -- |
| EPS | -62.68 | 24.40 | 2.20 | -- | -- |
| Book Value | -- | -- | -26.46 | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-23 | Mar-22 |
| EBIT-Margin
| -- | -- | -1,390.06 | -1,758.44 | -2,191.78 |
| Net Margin
| -- | -- | -1,486.36 | -- | -- |
| Return on equity
| -- | -- | -89.62 | -67.46 | -48.17 |
| Return on Capital
| -- | -- | -- | -55.76 | -42.34 |
| Return on Assets
| -- | -- | -43.99 | -49.45 | -35.72 |
| Debt to Equity (x)
| -- | -- | 0.42 | 0.30 | 0.14 |
The underlying data is unavailable.